GlycoNex Incorporation (TPEX:4168)
Taiwan · Delayed Price · Currency is TWD 29.40
+0.80 (2.80%)
Jan 21, 2026, 1:30 PM CST
GlycoNex Incorporation Market Cap
GlycoNex Incorporation has a market cap or net worth of 3.18 billion as of January 21, 2026. Its market cap has increased by 15.07% in one year.
Market Cap
3.18B
Enterprise Value
2.95B
Revenue
36.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.40
Market Cap Chart
Since December 16, 2011, GlycoNex Incorporation's market cap has increased from 1.51B to 3.18B, an increase of 111.03%. That is a compound annual growth rate of 5.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.18B | 14.17% |
| Dec 31, 2025 | 2.79B | 2.79% |
| Dec 31, 2024 | 2.71B | -16.13% |
| Dec 29, 2023 | 3.23B | -0.89% |
| Dec 30, 2022 | 3.26B | 13.02% |
| Dec 30, 2021 | 2.89B | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Lin BioScience | 31.15B |